The interference in correlated molecular mechanism obtained multi-drug resistance of mouse S180's tumour cell for different alkaloid

Zhongguo Zhongyao Zazhi

Volumn 30, Issue 23, 2005, Pages 1844-1848

  Li, Gui Hai ^a   Pan, Cheng Ye ^b   Sun, Fu Jun ^a   Yin, Ge Ping ^c   Wang, Xue Rong ^a  

^a Shandong Academy of Traditional Chinese Medicine   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Alkaloid; Fas; LRP; Mouse; Multi drug resistance; P170; TOPOII

Indexed keywords

ALKALOID; BENZYLISOQUINOLINE DERIVATIVE; BERBERINE DERIVATIVE; DNA TOPOISOMERASE (ATP HYDROLYSING); FAS ANTIGEN; FAS PROTEIN, MOUSE; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MATRINE; OXYMATRINE; QUINOLIZINE DERIVATIVE; RIBONUCLEOPROTEIN; TETRANDRINE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; FEMALE; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; METABOLISM; MOUSE; MULTIDRUG RESISTANCE; PATHOLOGY; RANDOMIZATION; SARCOMA 180;

ALKALOIDS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BENZYLISOQUINOLINES; BERBERINE ALKALOIDS; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; MALE; MICE; P-GLYCOPROTEIN; PLANTS, MEDICINAL; QUINOLIZINES; RANDOM ALLOCATION; SARCOMA 180; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 33748698706     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bracllcy G, Juranka P F, Ling V. Mechamism of multi-drug resistance. Biochim Biophys Acta, 1988, 948:87.
2. Gottesman M M, Pastan I. Biochemistry of multi-drug resistance meditated by the multi-drug transporter. Annu Rev Biochem, 1993, 62:385.
3. Scheffer G L, Wijngaard P L, Flens M J, et al. The drug resistance relaxed protein LRP is the human major vault protein. Nat Med, 1995, 1:578.
4. Hediey D U, Xie SX, Minden M D, et al. A Novel energy dependent mechanism redacing dannorbicin accumulation in acute myeloid lenk emia. Lenkemia, 1997, 11:48.
5. Schneider E, Hsiang Y U, Liu L F. DNA topoisconerases as anticancer drug targets. Adv Pharmacol, 1990, 21:149.
6. Walezak H, Krammer P H. The CD95 (APO-1/Fas) and the TRAIL (APO-2L)apoptosis systems. Exp Cell Res, 2000, 256:58.